Pharmaceutical - Financial, Humira

Filter

Current filters:

FinancialHumira

Popular Filters

Accelerated growth for AbbVie’s Humira lifts 3rd-quarter results above expectation

Accelerated growth for AbbVie’s Humira lifts 3rd-quarter results above expectation

27-10-2013

Shares of AbbVie were up 2.4% at $49.09 in afternoon trading on the New York Stock Exchange on Friday,…

AbbVieFinancialHumiraPharmaceutical

AbbVie beats expectations, as Humira keeps growing

28-07-2013

US drugmaker AbbVie (NYSE: ABBV), spun-out from Abbott Laboratories from the start of this year, reported…

AbbVieFinancialHumiraPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top